Search

Author/Creator Motzer, Robert J.

1. 31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part one: National Harbor, MD, USA. 9-13 November 2016. (16th November 2016)

Authors:
Lundqvist, Andreas; van Hoef, Vincent; Zhang, Xiaonan; Wennerberg, Erik; Lorent, Julie; Witt, Kristina; Sanz, Laia Masvidal; Liang, Shuo; Murray, Shannon; Larsson, Ola; Kiessling, Rolf; Mao, Yumeng; Sidhom, John-William; Bessell, Catherine A.; Havel, Jonathan; Schneck, Jonathan; Chan, Timothy A.;...
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 4(2016)Supplement 1
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. A Phase Ib Study of BEZ235, a Dual Inhibitor of Phosphatidylinositol 3-Kinase (PI3K) and Mammalian Target of Rapamycin (mTOR), in Patients With Advanced Renal Cell Carcinoma. (10th June 2016)

Authors:
Carlo, Maria I.; Molina, Ana M.; Lakhman, Yulia; Patil, Sujata; Woo, Kaitlin; DeLuca, John; Lee, Chung-Han; Hsieh, James J.; Feldman, Darren R.; Motzer, Robert J.; Voss, Martin H.
Journal:
Oncologist
Issue:
Volume 21:Number 7(2016)
Page Start:
787
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. A Phase Ib Study of BEZ235, a Dual Inhibitor of Phosphatidylinositol 3‐Kinase (PI3K) and Mammalian Target of Rapamycin (mTOR), in Patients With Advanced Renal Cell Carcinoma. (10th June 2016)

Authors:
Carlo, Maria I.; Molina, Ana M.; Lakhman, Yulia; Patil, Sujata; Woo, Kaitlin; DeLuca, John; Lee, Chung‐Han; Hsieh, James J.; Feldman, Darren R.; Motzer, Robert J.; Voss, Martin H.
Journal:
Oncologist
Issue:
Volume 21:Number 7(2016)
Page Start:
787
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Analysis by region of outcomes for patients with advanced renal cell carcinoma treated with cabozantinib or everolimus: a sub-analysis of the METEOR study. (2nd January 2022)

Authors:
Schmidinger, Manuela; Motzer, Robert J.; Rolland, Frederic; Staehler, Michael; Rink, Michael; Retz, Margitta; Csoszi, Tibor; McCaffrey, John A.; De Giorgi, Ugo; Caserta, Claudia; Duran, Ignacio; Benzaghou, Fawzi; Clary, Douglas O.; Albiges, Laurence; Choueiri, Toni K.; Tannir, Nizar M.
Journal:
Acta oncologica
Issue:
Volume 61:Number 1(2022)
Page Start:
52
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Avelumab plus axitinib vs sunitinib for advanced renal cell carcinoma: Japanese subgroup analysis from JAVELIN Renal 101. Issue 3 (5th February 2020)

Authors:
Uemura, Motohide; Tomita, Yoshihiko; Miyake, Hideaki; Hatakeyama, Shingo; Kanayama, Hiro‐omi; Numakura, Kazuyuki; Takagi, Toshio; Kato, Tomoyuki; Eto, Masatoshi; Obara, Wataru; Uemura, Hirotsugu; Choueiri, Toni K.; Motzer, Robert J.; Fujii, Yosuke; Kamei, Yoichi; Umeyama, Yoshiko; di Pietro, Ales...
Journal:
Cancer science
Issue:
Volume 111:Issue 3(2020)
Page Start:
907
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Axitinib in Metastatic Renal Cell Carcinoma: Results of a Pharmacokinetic and Pharmacodynamic Analysis. (28th March 2013)

Authors:
Rini, Brian I.; Garrett, May; Poland, Bill; Dutcher, Janice P.; Rixe, Olivier; Wilding, George; Stadler, Walter M.; Pithavala, Yazdi K.; Kim, Sinil; Tarazi, Jamal; Motzer, Robert J.
Journal:
Journal of clinical pharmacology
Issue:
Volume 53:Number 5(2013:May)
Page Start:
491
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. Characterizing fatigue associated with sunitinib and its impact on health‐related quality of life in patients with metastatic renal cell carcinoma. Issue 12 (13th March 2014)

Authors:
Cella, David; Davis, Mellar P.; Négrier, Sylvie; Figlin, Robert A.; Michaelson, M. Dror; Bushmakin, Andrew G.; Cappelleri, Joseph C.; Sandin, Rickard; Korytowsky, Beata; Charbonneau, Claudie; Matczak, Ewa; Motzer, Robert J.
Journal:
Cancer
Issue:
Volume 120:Issue 12(2014)
Page Start:
1871
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

8. Characterizing fatigue associated with sunitinib and its impact on health‐related quality of life in patients with metastatic renal cell carcinoma. Issue 12 (13th March 2014)

Authors:
Cella, David; Davis, Mellar P.; Négrier, Sylvie; Figlin, Robert A.; Michaelson, M. Dror; Bushmakin, Andrew G.; Cappelleri, Joseph C.; Sandin, Rickard; Korytowsky, Beata; Charbonneau, Claudie; Matczak, Ewa; Motzer, Robert J.
Journal:
Cancer
Issue:
Volume 120:Issue 12(2014)
Page Start:
1871
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

9. Clinical features, presentation, and tolerance of platinum‐based chemotherapy in germ cell tumor patients 50 years of age and older. Issue 14 (19th April 2013)

Authors:
Feldman, Darren R.; Voss, Martin H.; Jacobsen, Erin P.; Jia, Xiaoyu; Suarez, J. Andres; Turkula, Stefan; Sheinfeld, Joel; Bosl, George J.; Motzer, Robert J.; Patil, Sujata
Journal:
Cancer
Issue:
Volume 119:Issue 14(2013)
Page Start:
2574
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

10. Clinical features, presentation, and tolerance of platinum‐based chemotherapy in germ cell tumor patients 50 years of age and older. Issue 14 (19th April 2013)

Authors:
Feldman, Darren R.; Voss, Martin H.; Jacobsen, Erin P.; Jia, Xiaoyu; Suarez, J. Andres; Turkula, Stefan; Sheinfeld, Joel; Bosl, George J.; Motzer, Robert J.; Patil, Sujata
Journal:
Cancer
Issue:
Volume 119:Issue 14(2013)
Page Start:
2574
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗